There is no single age when every woman should stop getting mammograms. The most widely cited threshold is 75, the age at which the U.S. Preventive Services Task Force says the evidence is insufficient to recommend for or against continued screening. In practice, the decision depends less on your birthday and more on your overall health and how long you’re likely to live.
What the Major Guidelines Say
The three organizations most doctors rely on take slightly different approaches, but none of them name a hard cutoff age.
- U.S. Preventive Services Task Force (USPSTF): Recommends routine screening mammograms through age 74. For women 75 and older, the task force issued what it calls an “I statement,” meaning there isn’t enough evidence to weigh the benefits against the harms. This position was reaffirmed in the most recent update, which kept the same language from the 2016 recommendation.
- American Cancer Society (ACS): Does not set an upper age limit. Instead, it recommends continuing screening as long as a woman is in good health and expected to live at least 10 more years.
- American College of Obstetricians and Gynecologists (ACOG): Emphasizes shared decision-making, encouraging women and their doctors to weigh the benefits and harms individually rather than following a blanket rule.
The practical takeaway: if you’re 75 or older and in good health, no major guideline tells you to stop. But none of them push you to continue either. It becomes a personal decision.
Why 75 Isn’t a Magic Number
The reason guidelines get fuzzy at 75 is that the major clinical trials on mammography screening didn’t include many women over that age. Without strong trial data, organizations like the USPSTF can’t confidently say whether screening still saves lives in this group. That doesn’t mean it’s useless. It means the math gets more complicated.
Breast cancer grows slowly in most older women, and the benefits of catching it on a mammogram can take years to materialize. A tumor found today on a screening mammogram might not become life-threatening for 7 to 10 years. If your life expectancy is shorter than that window, the screening is unlikely to extend your life but can still lead to biopsies, surgery, and treatment you may not have needed.
The Problem of Overdiagnosis After 70
Overdiagnosis is the term for cancers detected on a mammogram that would never have caused symptoms or shortened a woman’s life. These tumors are real, but they grow so slowly (or not at all) that something else would have caused death first. The challenge is that once a cancer is found, there’s no reliable way to tell which ones are harmless, so nearly all of them get treated.
A National Cancer Institute study estimated that among women aged 70 to 74 diagnosed with breast cancer through screening, roughly 31% were overdiagnosed. That number climbed to 47% for women aged 75 to 84. For women with a life expectancy under five years, regardless of age, overdiagnosis exceeded 50%. That means more than half the cancers found in that group would never have caused harm, yet the women still went through the stress and physical toll of treatment.
These numbers don’t mean mammograms are harmful for all older women. They do mean the odds shift. At 50, the chance that a mammogram catches a cancer that truly threatens your life is relatively high. At 80, with multiple health conditions, the chance that it finds something you didn’t need to know about is substantial.
The 10-Year Life Expectancy Rule
The American Cancer Society’s recommendation to keep screening if you’re expected to live at least 10 more years is the closest thing to a practical guideline for older women. It shifts the question away from age and toward health status. A healthy, active 78-year-old with no major chronic conditions could reasonably expect to live well past 88, making continued screening worthwhile. A 72-year-old with serious heart disease, diabetes, and limited mobility may not benefit.
Your doctor can help estimate this, though it’s never an exact science. Factors that shorten the window include advanced heart or lung disease, kidney failure, dementia, and other conditions that significantly affect daily functioning. One study found that roughly 9% of women with advanced cancer elsewhere in their body were still getting routine cancer screening tests, a situation where the harms clearly outweigh any possible benefit.
What Medicare Covers
If cost or insurance is part of your decision, Medicare Part B covers one screening mammogram every 12 months for women 40 and older with no upper age limit. You won’t need a referral, and there’s no out-of-pocket cost for the screening itself. Medicare doesn’t require any special documentation to approve a mammogram at 80 or 90. The coverage decision is entirely separate from the medical question of whether screening still makes sense for you.
How to Decide for Yourself
If you’re approaching or past 75, the decision comes down to a few key questions. How is your overall health? Do you have chronic conditions that significantly affect your daily life or shorten your expected lifespan? And how do you personally feel about the possibility of finding a cancer that might never cause trouble versus missing one that could?
Some women find peace of mind in continued screening and are willing to accept the risk of a false alarm or unnecessary biopsy. Others, especially those already managing serious health problems, prefer to stop screening and avoid the cascade of follow-up tests that can come from an abnormal result. Neither choice is wrong. The guidelines deliberately leave this as a conversation rather than a rule because the right answer genuinely varies from person to person.
If you do continue screening past 75, the standard recommendation remains one mammogram every one to two years, the same interval used for younger women. There’s no evidence that screening more frequently improves outcomes at any age.